Related Experiment Videos
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas
Cancer Chemotherapy and Pharmacology
|January 1, 1985
Abstract:
In all 63 patients were treated monthly with a combination of mitomycin, doxorubicin, and cisplatin, and 27 (43%) experienced objective regression of their advanced sarcomas during a 3-month trial. The observed regression rate is numerically higher than any previously observed at our institution.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.
American journal of clinical oncology·2002
Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study.
Cancer chemotherapy and pharmacology·2026
Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.
Cancer chemotherapy and pharmacology·2026
Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy.
Cancer chemotherapy and pharmacology·2026
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.
Cancer chemotherapy and pharmacology·2026
Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.
Cancer chemotherapy and pharmacology·2026
Main pulmonary artery enlargement during bevacizumab therapy in KRAS-mutant metastatic colon cancer.
Cancer chemotherapy and pharmacology·2026
Obsessive-Compulsive Disorder in Adulthood: Etiology, Diagnosis, and Treatment.
Deutsches Arzteblatt international·2026
Functional relevance and mechanisms of necroptosis in ischemia-reperfusion injury.
Acta neurobiologiae experimentalis·2026
[Producing evidence for all: geriatric oncology and the challenge of equity in health care].
La Revue du praticien·2026
Individual and Cumulative Impacts of Diagnosis-to-Treatment Interval and Radiotherapy Interval on Survival in Nasopharyngeal Cancer.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Comparative efficacy of palonosetron and ondansetron for chemotherapy-induced nausea and vomiting in pediatric and adult populations: A systematic review and meta-analysis of randomized controlled trials.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026